2025 European guideline on the management of Chlamydia trachomatis infections

JA White; NHTM Dukers-Muijrers; CJPA Hoebe; CR Kenyon; JDC Ross; M Unemo

doi:10.1177/09564624251323678

2025 European guideline on the management of Chlamydia trachomatis infections

JA White, NHTM Dukers-Muijrers, CJPA Hoebe, CR Kenyon, JDC Ross, M Unemo

Sexually Transmitted Infections

Research output: Contribution to journal › A1: Web of Science-article › peer-review

Abstract

Sexually transmitted Chlamydia trachomatis infections remain common globally and most frequently are asymptomatic. The 2025 European C. trachomatis guideline provides up-to-date guidance regarding indications for testing and treatment of C. trachomatis infections. It includes advice on urogenital and extragenital C. trachomatis testing including the use of self-collected specimens; recommendation to use only validated NAATs for diagnosis; and recommendation to treat all C. trachomatis infections with doxycycline as first line in preference to single-dose azithromycin regimens. The absence of evidence and limited value of broad screening in asymptomatic populations for C. trachomatis infections is also discussed.

Original language	English
Journal	International Journal of STD & AIDS
Number of pages	16
ISSN	0956-4624
DOIs	https://doi.org/10.1177/09564624251323678
Publication status	E-pub ahead of print - 2025

Keywords

<italic>Chlamydia trachomatis</italic>
Europe
Antibiotic
Diagnosis
Treatment

Access to Document

10.1177/09564624251323678

Cite this

@article{78609c0822d6408dae48fea3830d9339,

title = "2025 European guideline on the management of Chlamydia trachomatis infections",

abstract = "Sexually transmitted Chlamydia trachomatis infections remain common globally and most frequently are asymptomatic. The 2025 European C. trachomatis guideline provides up-to-date guidance regarding indications for testing and treatment of C. trachomatis infections. It includes advice on urogenital and extragenital C. trachomatis testing including the use of self-collected specimens; recommendation to use only validated NAATs for diagnosis; and recommendation to treat all C. trachomatis infections with doxycycline as first line in preference to single-dose azithromycin regimens. The absence of evidence and limited value of broad screening in asymptomatic populations for C. trachomatis infections is also discussed.",

keywords = "<italic>Chlamydia trachomatis</italic>, Europe, Antibiotic, Diagnosis, Treatment",

author = "JA White and NHTM Dukers-Muijrers and CJPA Hoebe and CR Kenyon and JDC Ross and M Unemo",

note = "FTX abonnement",

year = "2025",

doi = "10.1177/09564624251323678",

language = "English",

journal = "International Journal of STD & AIDS",

issn = "0956-4624",

publisher = "Sage Publications",

}

TY - JOUR

T1 - 2025 European guideline on the management of Chlamydia trachomatis infections

AU - White, JA

AU - Dukers-Muijrers, NHTM

AU - Hoebe, CJPA

AU - Kenyon, CR

AU - Ross, JDC

AU - Unemo, M

N1 - FTX abonnement

PY - 2025

Y1 - 2025

N2 - Sexually transmitted Chlamydia trachomatis infections remain common globally and most frequently are asymptomatic. The 2025 European C. trachomatis guideline provides up-to-date guidance regarding indications for testing and treatment of C. trachomatis infections. It includes advice on urogenital and extragenital C. trachomatis testing including the use of self-collected specimens; recommendation to use only validated NAATs for diagnosis; and recommendation to treat all C. trachomatis infections with doxycycline as first line in preference to single-dose azithromycin regimens. The absence of evidence and limited value of broad screening in asymptomatic populations for C. trachomatis infections is also discussed.

AB - Sexually transmitted Chlamydia trachomatis infections remain common globally and most frequently are asymptomatic. The 2025 European C. trachomatis guideline provides up-to-date guidance regarding indications for testing and treatment of C. trachomatis infections. It includes advice on urogenital and extragenital C. trachomatis testing including the use of self-collected specimens; recommendation to use only validated NAATs for diagnosis; and recommendation to treat all C. trachomatis infections with doxycycline as first line in preference to single-dose azithromycin regimens. The absence of evidence and limited value of broad screening in asymptomatic populations for C. trachomatis infections is also discussed.

KW - <italic>Chlamydia trachomatis</italic>

KW - Europe

KW - Antibiotic

KW - Diagnosis

KW - Treatment

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=itm_wosliteitg&SrcAuth=WosAPI&KeyUT=WOS:001436493600001&DestLinkType=FullRecord&DestApp=WOS_CPL

U2 - 10.1177/09564624251323678

DO - 10.1177/09564624251323678

M3 - A1: Web of Science-article

C2 - 40037375

SN - 0956-4624

JO - International Journal of STD & AIDS

JF - International Journal of STD & AIDS

ER -

2025 European guideline on the management of Chlamydia trachomatis infections

Abstract

Keywords

Access to Document

Other files and links

Cite this